By:
On:
In: Health
With: 0 Comments

Stem cell transplants can cure patients with high-risk leukemia or lymphoma.  Graft-versus-host disease (GVHD) is a potentially life-threatening side effect that occurs when the donor’s immune cells attack the recipient’s normal tissues. Moffitt Cancer Center researchers are trying to identify new drug targets to reduce the risk of GVHD. Their new study, publishedContinue Reading